Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Neuroscience Research|July 6, 2000
Neuropathology of synuclein aggregatesJ E Duda, V M Lee, J Q TrojanowskiExperimental Neurology|January 5, 2000
The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseasesJ E Duda, U Shah, S E Arnold, et al.Experimental Neurology|November 22, 2001
Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neuronsB I Giasson, J E Duda, M S Forman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2005
Multiple pathologies in a patient with a progressive neurodegenerative syndromeT-W Liang, M S Forman, J E Duda, et al.Journal of Neuroscience Research|February 19, 2000
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's diseaseB I Giasson, R Jakes, M Goedert, et al.Neurology|November 26, 2009
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseS Hoops, S Nazem, A D Siderowf, et al.Science (New York, N.Y.)|November 4, 2000
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesionsB I Giasson, J E Duda, I V Murray, et al.Neuropathology and Applied Neurobiology|October 15, 2010
TDP-43 pathology occurs infrequently in multiple system atrophyF Geser, J A Malunda, H I Hurtig, et al.The American Journal of Pathology|November 14, 2000
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathiesJ E Duda, B I Giasson, Q Chen, et al.Neurology|August 4, 2010
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson diseaseD Weintraub, S Mavandadi, E Mamikonyan, et al.Pageof 2